1. Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery

   • Louis A. Aliperti
   • Jarrod D. Predina
   • Sunil Singhal

   Translational Research and Biomarkers 16 December 2010 Pages: 603 - 607

   

2. Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

   • Matthew H. G. Katz
   • Peter W. T. Pisters
   • Jason B. Fleming

   Pancreatic Tumors 07 December 2010 Pages: 608 - 610

3. Quality Measurement in Cancer Care Delivery

   • Nabil Wasif
   • Janice N. Cormier
   • Stanley P. L. Leong

   Healthcare Policy and Outcomes 05 January 2011 Pages: 611 - 618

   

4. Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer

   • Jayme B. Stokes
   • Norris J. Nolan
   • Todd W. Bauer

   Pancreatic Tumors 07 January 2011 Pages: 619 - 627

   

5. Single-Access Transumbilical Diagnostic Laparoscopy for Pancreatic Tumor Using Curved and Reusable Instruments

   • Giovanni Dapri
   • Pietro Carnevali
   • Guy-Bernard Cadière

   Original Article - Pancreatic Tumors 16 November 2010 Pages: 628 - 628

6. A Qualitative Assessment of a Provincial Quality Improvement Strategy for Pancreatic Cancer Surgery

   • Frances C. Wright
   • Margaret Fitch
   • Marko Simunovic

   Pancreatic Tumors 28 September 2010 Pages: 629 - 635

7. Prospective Evaluation of Laparoscopic Celiac Plexus Block in Patients with Unresectable Pancreatic Adenocarcinoma

   • Peter J. Allen
   • Joanne Chou
   • Murray F. Brennan

   Pancreatic Tumors 17 October 2010 Pages: 636 - 641

   

8. Robotic Left Pancreatectomy for Pancreatic Solid Pseudopapillary Tumor

   • Dimitrios Ntourakis
   • Ettore Marzano
   • Patrick Pessaux

   Pancreatic Tumors 19 November 2010 Pages: 642 - 643

9. Analysis of Prognostic Factors and a Proposed New Classification for Invasive Papillary Mucinous Neoplasms

   • Jin-Young Jang
   • Dae Wook Hwang
   • Sun-Whe Kim

   Hepatobiliary Tumors 06 October 2010 Pages: 644 - 650

   

10. Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma

    • Yoshiaki Murakami
    • Kenichiro Uemura
    • Taijiro Sueda

    Hepatobiliary Tumors 14 October 2010 Pages: 651 - 658

    

11. Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases

    • Dennis A. Wicherts
    • Robbert J. de Haas
    • René Adam

    Hepatobiliary Tumors Open access 26 October 2010 Pages: 659 - 669

    

12. Treatment and Outcome of Patients with Gastric Remnant Cancer After Resection for Peptic Ulcer Disease

    • James J. Mezhir
    • Mithat Gonen
    • Daniel G. Coit

    Gastrointestinal Oncology 10 November 2010 Pages: 670 - 676

    

13. Preoperative Chemotherapy with Cisplatin and Docetaxel Followed by Surgery and Clip-Oriented Postoperative Chemoradiation in Patients with Localized Gastric or Gastroesophageal Junction Adenocarcinoma: Results from a Phase II Feasibility Study

    • G. Spizzo
    • D. Öfner
    • G. Mühlmann

    Gastrointestinal Oncology 10 November 2010 Pages: 677 - 683

    

14. Outcome Standards for an Organ Preservation Strategy in Stage II and III Rectal Adenocarcinoma after Neoadjuvant Chemoradiation

    • Albert M. Wolthuis
    • Freddy Penninckx
    • André D’Hoore

    Colorectal Cancer 15 September 2010 Pages: 684 - 690

    

15. 2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World

    • W. van Gijn
    • C. J. H. van de Velde

    Colorectal Cancer Open access 16 September 2010 Pages: 691 - 696

16. Operative Salvage for Retroperitoneal Nodal Recurrence in Colorectal Cancer: A Systematic Review

    • Thomas WaiThong Ho
    • Lloyd A. Mack
    • Walley J. Temple

    Colorectal Cancer 18 September 2010 Pages: 697 - 703

17. Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer

    • Jeonghyun Kang
    • Hyuk Hur
    • Kang Young Lee

    Colorectal Cancer 21 September 2010 Pages: 704 - 710

    

18. Loss of E-cadherin and MUC2 Expressions Correlated with Poor Survival in Patients with Stages II and III Colorectal Carcinoma

    • Haeyoun Kang
    • Byung Soh Min
    • Hoguen Kim

    Colorectal Cancer 24 September 2010 Pages: 711 - 719

    

19. Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution

    • Roberta Sanfilippo
    • Rosalba Miceli
    • Alessandro Gronchi

    Bone and Soft Tissue Sarcomas 28 September 2010 Pages: 720 - 725

    

20. Forequarter Amputation

    • Constantine P. Karakousis
    • John L. Butsch

    Bone and Soft Tissue Sarcomas 24 December 2010 Pages: 726 - 726

21. Sentinel Lymph Node Biopsy in Patients with Previous Ipsilateral Complete Axillary Lymph Node Dissection

    • Paramjeet Kaur
    • John V. Kiluk
    • Charles E. Cox

    Breast Oncology 01 July 2010 Pages: 727 - 732

    

22. Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?

    • M. Golshan
    • J. E. Garber
    • P. Ryan

    Breast Oncology 30 September 2010 Pages: 733 - 737

23. Impact of Preoperative Ultrasonography and Fine-Needle Aspiration of Axillary Lymph Nodes on Surgical Management of Primary Breast Cancer

    • So Hee Park
    • Min Jung Kim
    • Eun-Kyung Kim

    Breast Oncology 02 October 2010 Pages: 738 - 744

    

24. Breast Cancer Surgery Trend Changes Since the Introduction of BRCA1/2 Mutation Screening: A Retrospective Cohort Analysis of 158 Mutation Carriers Treated at a Single Institution

    • Angela Mislowsky
    • Susan Domchek
    • Julia Tchou

    Breast Oncology 23 October 2010 Pages: 745 - 751

    

25. Atypical Ductal Hyperplasia in Directional Vacuum-Assisted Biopsy of Breast Microcalcifications: Considerations for Surgical Excision

    • Christopher V. Nguyen
    • Constance T. Albarracin
    • Nour Sneige

    Breast Oncology 23 October 2010 Pages: 752 - 761

    

26. Electronic Synoptic Operative Reporting for Thyroid Surgery using an Electronic Data Management System: Potential for Prospective Multicenter Data Collection

    • N. Gopalakrishna Iyer
    • Iain J. Nixon
    • Ashok R. Shaha

    Endocrine Tumors 30 September 2010 Pages: 762 - 766

    

27. Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer

    • Iain J. Nixon
    • Frank L. Palmer
    • Ian Ganly

    Endocrine Tumors 30 September 2010 Pages: 767 - 770

28. Changing Intraoperative Parathyroid Hormone Collection Sites from Peripheral to Central Does Not Affect Predictive Accuracy during Minimally Invasive Parathyroidectomy

    • Sherif R. Z. Abdel-Misih
    • James T. Broome
    • John E. Phay

    Endocrine Tumors 14 October 2010 Pages: 771 - 776

    

29. The Value of Postoperative Parathyroid Hormone Levels in Predicting the Need for Long-Term Vitamin D Supplementation after Total Thyroidectomy

    • Tracy S. Wang
    • Ashley K. Cayo
    • Tina W. F. Yen

    Endocrine Tumors 19 October 2010 Pages: 777 - 781

30. Radiation-Induced Bowel Complications: Laparoscopic Versus Open Staging of Gynecologic Malignancy

    • Fabio Ghezzi
    • Antonella Cromi
    • Paolo Vanoli

    Gynecologic Oncology 20 October 2010 Pages: 782 - 791

    

31. Diagnostic Value of BRAF^V600E Mutation Analysis of Thyroid Nodules According to Ultrasonographic Features and the Time of Aspiration

    • Hee Jung Moon
    • Eun-Kyung Kim
    • Jin Young Kwak

    Head and Neck Oncology 14 October 2010 Pages: 792 - 799

    

32. Surgical Management of Metastases to the Thyroid Gland

    • Iain J. Nixon
    • Monica Whitcher
    • Ian Ganly

    Head and Neck Oncology 03 November 2010 Pages: 800 - 804

33. Impact of uPA System Gene Polymorphisms on the Susceptibility of Environmental Factors to Carcinogenesis and the Development of Clinicopathology of Oral Cancer

    • Chia-Jui Weng
    • Chiao-Wen Lin
    • Shun-Fa Yang

    Head and Neck Oncology 02 December 2010 Pages: 805 - 812

34. Assessment of Cosmesis After Breast Reconstruction Surgery: a Systematic Review

    • Shelley Potter
    • Diana Harcourt
    • Jane Blazeby

    Reconstructive Oncology 23 October 2010 Pages: 813 - 823

    

35. An Elevated Body Mass Index Does Not Reduce Survival After Esophagectomy for Cancer

    • Marcovalerio Melis
    • Jill M. Weber
    • Kenneth L. Meredith

    Gastrointestinal Oncology 24 September 2010 Pages: 824 - 831

    

36. Correlation Between gp96 Expression and the Surgical Outcome in Patients With Esophageal Squamous Cell Carcinoma

    • Yasunori Akutsu
    • Hisahiro Matsubara
    • Gulbostan Yusup

    Thoracic Oncology 14 September 2010 Pages: 832 - 837

    

37. Thoracoscopic Esophagectomy in Prone Position

    • Guy Bernard Cadière
    • Giovanni Dapri
    • Amin Rajan

    Thoracic Oncology 23 October 2010 Pages: 838 - 838

38. Impact of Surgical Experience on In-Hospital Complication Rates in Patients Undergoing Minimally Invasive Prostatectomy: A Population-Based Study

    • Lars Budäus
    • Maxine Sun
    • Pierre I. Karakiewicz

    Urologic Oncology 16 October 2010 Pages: 839 - 847

    

39. Induction of the Mitochondria Apoptosis Pathway by Phytohemagglutinin Erythroagglutinating in Human Lung Cancer Cells

    • Wei-Ting Kuo
    • Yung-Jen Ho
    • Chun-Hsu Yao

    Thoracic Oncology 06 October 2010 Pages: 848 - 856

    

40. CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

    • Qian-Ze Dong
    • Yang Wang
    • En-Hua Wang

    Translational Research and Biomarkers 15 September 2010 Pages: 857 - 865

    

41. In Vitro Sarcoma Cells Release a Lipophilic Substance That Activates the Pain Transduction System via TRPV1

    • Meeghan A. Lautner
    • Shivani B. Ruparel
    • Kenneth M. Hargreaves

    Translational Research and Biomarkers 15 September 2010 Pages: 866 - 871

    

42. Expression and Clinical Significance of Hepatoma-Derived Growth Factor as a Prognostic Factor in Human Hilar Cholangiocarcinoma

    • Yan-feng Liu
    • Rui Zhao
    • Ke-sen Xu

    Translational Research and Biomarkers 17 September 2010 Pages: 872 - 879

    

43. Role of Survivin Gene Promoter Polymorphism (−31G>C) in Susceptibility and Survival of Esophageal Cancer in Northern India

    • Rohit Upadhyay
    • Rohini Khurana
    • Balraj Mittal

    Translational Research and Biomarkers 19 October 2010 Pages: 880 - 887

    

44. Prognostic Significance of CD151 Expression in Esophageal Squamous Cell Carcinoma with Aggressive Cell Proliferation and Invasiveness

    • Shigemasa Suzuki
    • Tatsuya Miyazaki
    • Hiroyuki Kuwano

    Translational Research and Biomarkers 27 October 2010 Pages: 888 - 893

    

45. Predicting Individual Prognosis for Patients Undergoing Resection of Colorectal Liver Metastases

    • Jinggui Chen
    • Guangfa Zhao

    Hepatobiliary Tumors 18 August 2010 Pages: 894 - 895

46. Regarding: Epithelial-Mesenchymal Transition Induced by Hepatitis C Virus Core Protein in Cholangiocarcinoma

    • Clara Balsano
    • Beatrice Conti
    • Mario Arciello

    Translational Research and Biomarkers 20 July 2010 Pages: 896 - 896

47. Epithelial–Mesenchymal Transition and LOXL2: Consideration Continues

    • Dajiang Li
    • Tianyu Li
    • Shuguang Wang

    Translational Research and Biomarkers 20 July 2010 Pages: 897 - 897

48. Lymphadenectomy for Melanoma: Toward a Videoscopic Approach

    • Antonio Sommariva
    • Sandro Pasquali
    • Carlo Riccardo Rossi

    Melanomas 03 August 2010 Pages: 898 - 899

49. In Reply: Continuing Discussion Regarding Novel Technique for Inguinal Lymphadenectomy

    • Keith Delman
    • Viraj Master

    Melanomas 23 July 2010 Pages: 900 - 900

50. Letter to the Editor

    • Massimiliano Mistrangelo
    • Fernando Munoz
    • Enrica Milanesi

    Gastrointestinal Oncology 18 August 2010 Pages: 901 - 901